Analysis of lidocaine on the COBAS® INTEGRA

Annals of Clinical and Laboratory Science

Volumn 27, Issue 2, 1997, Pages 105-115

  Liu Allison, Linda Y ^a   Hui, Raymond A ^a   Schwenzer, Kathryn S ^a  

^a HOFFMANN LA ROCHE INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEPARIN; LIDOCAINE;

ARTICLE; DIAGNOSTIC ACCURACY; DRUG BLOOD LEVEL; DRUG MONITORING; FLUORESCENCE POLARIZATION IMMUNOASSAY; PRIORITY JOURNAL;

AUTOANALYSIS; CHEMISTRY, CLINICAL; HEPARIN; HUMANS; INDICATORS AND REAGENTS; LIDOCAINE; PLASMA; QUALITY CONTROL; SENSITIVITY AND SPECIFICITY;

EID: 0030914132     PISSN: 00917370     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. ASTRA®, Westborough MA, Xylocaine®. 1993; 7: 021679R00.
2. Pieper JA, Evans WE, Sehentag JJ, et al. In: Applied Pharmacokinetics. 2nd. ed, Spokane, WA: Applied Therapeutics Inc., 1986:639-81.
3. Tarn YK, Ke J, Coutts RT, et al. Pharmaceutical Res, 1990;7:504-7.
4. Palmer SM, Kaufman RA, Salamone SJ, et al. GOBAS® INTEGRA: clinical laboratory instrument with continuous and random-access capabilities. Clin Chem 1995;41:1751-60.
5. Dandliker WB, Feigen GA. Quantification of the antigen-antibody reaction by the polarization of fluorescence. Biochem Biophys Res Comm 1961;5:299-304.
6. Dandliker WB, Schaprio HC, Meduski JW, et al. Application of fluorescence polarization to the antigen-antibody reaction. Theory and experimental method. Immunochemistry 1964;1:165-91.
7. Murakami M, Inukai N, Koda A, et al. An improved synthesis of metoclopramide. Chem Pharm Bull 1971;19:1696-99.
8. Dewar MJS, Scott JMW. The Orton rearrangement. Part I. Preparation and properties of N-Bromo- and N-chloro-2:6-dimethylacetanilide. J Chem Soc 1955;00:1845-7.
9. af Ekenstam BT, Bovin C. L-N-n-propylpipecolic acid 2,6-xylidide. US Patent 4,695,576.
10. National Committee for Clinical Laboratory Standards. User Evaluation of Precision Performance of Clinical Chemistry Devices; Tentative Guideline. Villanova, PA: NCCLS, 1992:4(12), NCCLS Publication EP5-T2.
11. National Committee for Clinical Laboratory Standards. Interference Testing in Clinical Chemistry; Proposed Guideline. Villanova, PA: NCCLS; 1986: 6(13), NCCLS Publication EP7-P.
12. College of American Pathologists, Therapeutic Drug Monitoring Series 2 Survey, Set Z-C. Northfield, IL. 1995:Set Z-C.
13. Alderman EL, Kerber RE, Harrison DC. Am J Cardiol 1974;34:342-9.
14. Remmel RP, Copa AK, Angaran DM. Pharmaceutical Res 1991;8:127-30.